David A. Isenberg

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 404 publications

Real-world performance of myositis antibody panels: a single-centre experience.

Real-world performance of myositis antibody panels: a single-centre experience.

Journal: Rheumatology (Oxford, England)

Published: June 23, 2026

Morbidity and mortality in primary versus secondary antiphospholipid syndrome: A single-center study using the 2023 ACR/EULAR criteria.

Morbidity and mortality in primary versus secondary antiphospholipid syndrome: A single-center study using the 2023 ACR/EULAR criteria.

Journal: Lupus

Published: May 06, 2026

Executive Summary: The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus.

Executive Summary: The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus.

Journal: Rheumatology (Oxford, England)

Published: April 20, 2026

The role of monoclonal antibodies in the treatment of lupus nephritis.

The role of monoclonal antibodies in the treatment of lupus nephritis.

Journal: Expert opinion on biological therapy

Published: April 07, 2026

Anatomy of a Cohort: 40-Year Follow-Up of a Sjögren's Cohort.

Anatomy of a Cohort: 40-Year Follow-Up of a Sjögren's Cohort.

Journal: Journal of clinical medicine

Published: March 31, 2026

Controlling cardiovascular risk factors reduces progression of atherosclerosis in a multiethnic cohort of patients with lupus.

Controlling cardiovascular risk factors reduces progression of atherosclerosis in a multiethnic cohort of patients with lupus.

Journal: Lupus science & medicine

Published: February 03, 2026

Prolonged serologically active clinically quiescent systemic lupus erythematosus: a longitudinal study on the role of IgG anti-dsDNA and C3.

Prolonged serologically active clinically quiescent systemic lupus erythematosus: a longitudinal study on the role of IgG anti-dsDNA and C3.

Journal: Rheumatology (Oxford, England)

Published: January 21, 2026

The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus.

The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus.

Journal: Rheumatology (Oxford, England)

Published: December 19, 2025

Clinical characteristics and long-term outcomes in SLE-myositis overlap syndrome: a controlled retrospective cohort study.

Clinical characteristics and long-term outcomes in SLE-myositis overlap syndrome: a controlled retrospective cohort study.

Journal: Rheumatology (Oxford, England)

Published: December 16, 2025

Comparative Analysis of Clinical Trials of Biologic Drugs for Patients with Primary Sjögren's Syndrome.

Comparative Analysis of Clinical Trials of Biologic Drugs for Patients with Primary Sjögren's Syndrome.

Journal: Journal of clinical medicine

Published: November 13, 2025

Characterizing the NIH Activity and Chronicity Indices in 2 Independent Lupus Nephritis Cohorts.

Characterizing the NIH Activity and Chronicity Indices in 2 Independent Lupus Nephritis Cohorts.

Journal: Kidney international reports

Published: November 06, 2025

Assessment of the use of biologic drugs in the treatment of primary antiphospholipid syndrome.

Assessment of the use of biologic drugs in the treatment of primary antiphospholipid syndrome.

Journal: Rheumatology (Oxford, England)

Published: October 22, 2025

Showing 1-12 of 404

Last Updated: 09/26/2026